- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-5-5-mer
- Ligands
- 5 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 5 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN.2: 13 residues within 4Å:- Chain A: N.204, R.247, V.249, S.250, R.251, S.266, R.268
- Chain B: N.417, Y.418, G.487, S.490, T.497, D.500
3 PLIP interactions:2 interactions with chain B, 1 interactions with chain A- Hydrogen bonds: B:Y.418, B:D.500, A:R.247, A:R.251, A:N.252, B:T.497, B:T.497
NAG-NAG-BMA-MAN-MAN.13: 13 residues within 4Å:- Chain C: N.204, R.247, V.249, S.250, R.251, S.266, R.268
- Chain D: N.417, Y.418, G.487, S.490, T.497, D.500
3 PLIP interactions:2 interactions with chain D, 1 interactions with chain C- Hydrogen bonds: D:Y.418, D:D.500, C:R.247, C:R.251, C:N.252, D:T.497, D:T.497
NAG-NAG-BMA-MAN-MAN.24: 13 residues within 4Å:- Chain E: N.204, R.247, V.249, S.250, R.251, S.266, R.268
- Chain F: N.417, Y.418, G.487, S.490, T.497, D.500
3 PLIP interactions:1 interactions with chain E, 2 interactions with chain F- Hydrogen bonds: E:R.247, E:R.251, F:Y.418, F:D.500, E:N.252, F:T.497, F:T.497
NAG-NAG-BMA-MAN-MAN.35: 13 residues within 4Å:- Chain G: N.204, R.247, V.249, S.250, R.251, S.266, R.268
- Chain H: N.417, Y.418, G.487, S.490, T.497, D.500
3 PLIP interactions:2 interactions with chain H, 1 interactions with chain G- Hydrogen bonds: H:Y.418, H:D.500, G:R.247, G:R.251, G:N.252, H:T.497, H:T.497
NAG-NAG-BMA-MAN-MAN.46: 13 residues within 4Å:- Chain I: N.204, R.247, V.249, S.250, R.251, S.266, R.268
- Chain J: N.417, Y.418, G.487, S.490, T.497, D.500
3 PLIP interactions:1 interactions with chain I, 2 interactions with chain J- Hydrogen bonds: I:R.247, I:R.251, J:Y.418, J:D.500, J:T.497, J:T.497, I:N.252
- 5 x R16: HEXADECANE(Non-covalent)
R16.3: 8 residues within 4Å:- Chain A: I.285, W.292, P.380, F.383, S.384, N.387, W.391
- Ligands: D10.6
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:I.285, A:I.285, A:W.292, A:P.380, A:F.383, A:W.391, A:W.391, A:W.391
R16.14: 8 residues within 4Å:- Chain C: I.285, W.292, P.380, F.383, S.384, N.387, W.391
- Ligands: D10.17
8 PLIP interactions:8 interactions with chain C- Hydrophobic interactions: C:I.285, C:I.285, C:W.292, C:P.380, C:F.383, C:W.391, C:W.391, C:W.391
R16.25: 8 residues within 4Å:- Chain E: I.285, W.292, P.380, F.383, S.384, N.387, W.391
- Ligands: D10.28
8 PLIP interactions:8 interactions with chain E- Hydrophobic interactions: E:I.285, E:I.285, E:W.292, E:P.380, E:F.383, E:W.391, E:W.391, E:W.391
R16.36: 8 residues within 4Å:- Chain G: I.285, W.292, P.380, F.383, S.384, N.387, W.391
- Ligands: D10.39
8 PLIP interactions:8 interactions with chain G- Hydrophobic interactions: G:I.285, G:I.285, G:W.292, G:P.380, G:F.383, G:W.391, G:W.391, G:W.391
R16.47: 8 residues within 4Å:- Chain I: I.285, W.292, P.380, F.383, S.384, N.387, W.391
- Ligands: D10.50
8 PLIP interactions:8 interactions with chain I- Hydrophobic interactions: I:I.285, I:I.285, I:W.292, I:P.380, I:F.383, I:W.391, I:W.391, I:W.391
- 20 x D10: DECANE(Non-covalent)
D10.4: 6 residues within 4Å:- Chain A: I.289, V.293, W.296
- Chain I: F.356, Y.359
- Ligands: D10.5
Ligand excluded by PLIPD10.5: 2 residues within 4Å:- Chain A: R.376
- Ligands: D10.4
Ligand excluded by PLIPD10.6: 4 residues within 4Å:- Chain A: S.384, N.387, W.391
- Ligands: R16.3
Ligand excluded by PLIPD10.7: 4 residues within 4Å:- Chain A: F.386, V.389, Y.393, Y.394
Ligand excluded by PLIPD10.15: 6 residues within 4Å:- Chain A: F.356, Y.359
- Chain C: I.289, V.293, W.296
- Ligands: D10.16
Ligand excluded by PLIPD10.16: 2 residues within 4Å:- Chain C: R.376
- Ligands: D10.15
Ligand excluded by PLIPD10.17: 4 residues within 4Å:- Chain C: S.384, N.387, W.391
- Ligands: R16.14
Ligand excluded by PLIPD10.18: 4 residues within 4Å:- Chain C: F.386, V.389, Y.393, Y.394
Ligand excluded by PLIPD10.26: 6 residues within 4Å:- Chain C: F.356, Y.359
- Chain E: I.289, V.293, W.296
- Ligands: D10.27
Ligand excluded by PLIPD10.27: 2 residues within 4Å:- Chain E: R.376
- Ligands: D10.26
Ligand excluded by PLIPD10.28: 4 residues within 4Å:- Chain E: S.384, N.387, W.391
- Ligands: R16.25
Ligand excluded by PLIPD10.29: 4 residues within 4Å:- Chain E: F.386, V.389, Y.393, Y.394
Ligand excluded by PLIPD10.37: 6 residues within 4Å:- Chain E: F.356, Y.359
- Chain G: I.289, V.293, W.296
- Ligands: D10.38
Ligand excluded by PLIPD10.38: 2 residues within 4Å:- Chain G: R.376
- Ligands: D10.37
Ligand excluded by PLIPD10.39: 4 residues within 4Å:- Chain G: S.384, N.387, W.391
- Ligands: R16.36
Ligand excluded by PLIPD10.40: 4 residues within 4Å:- Chain G: F.386, V.389, Y.393, Y.394
Ligand excluded by PLIPD10.48: 6 residues within 4Å:- Chain G: F.356, Y.359
- Chain I: I.289, V.293, W.296
- Ligands: D10.49
Ligand excluded by PLIPD10.49: 2 residues within 4Å:- Chain I: R.376
- Ligands: D10.48
Ligand excluded by PLIPD10.50: 4 residues within 4Å:- Chain I: S.384, N.387, W.391
- Ligands: R16.47
Ligand excluded by PLIPD10.51: 4 residues within 4Å:- Chain I: F.386, V.389, Y.393, Y.394
Ligand excluded by PLIP- 5 x HSM: HISTAMINE(Non-covalent)
HSM.8: 8 residues within 4Å:- Chain A: Y.152, E.210, S.211, Y.212, F.255, Y.260
- Chain C: D.98, Y.117
7 PLIP interactions:4 interactions with chain C, 3 interactions with chain A- Hydrophobic interactions: C:Y.117
- Hydrogen bonds: C:D.98, C:D.98, A:Y.152, A:E.210, A:T.257
- pi-Stacking: C:Y.117
HSM.19: 8 residues within 4Å:- Chain C: Y.152, E.210, S.211, Y.212, F.255, Y.260
- Chain E: D.98, Y.117
7 PLIP interactions:3 interactions with chain C, 4 interactions with chain E- Hydrogen bonds: C:Y.152, C:E.210, C:T.257, E:D.98, E:D.98
- Hydrophobic interactions: E:Y.117
- pi-Stacking: E:Y.117
HSM.30: 8 residues within 4Å:- Chain E: Y.152, E.210, S.211, Y.212, F.255, Y.260
- Chain G: D.98, Y.117
7 PLIP interactions:3 interactions with chain E, 4 interactions with chain G- Hydrogen bonds: E:Y.152, E:E.210, E:T.257, G:D.98, G:D.98
- Hydrophobic interactions: G:Y.117
- pi-Stacking: G:Y.117
HSM.41: 8 residues within 4Å:- Chain G: Y.152, E.210, S.211, Y.212, F.255, Y.260
- Chain I: D.98, Y.117
7 PLIP interactions:4 interactions with chain I, 3 interactions with chain G- Hydrophobic interactions: I:Y.117
- Hydrogen bonds: I:D.98, I:D.98, G:Y.152, G:E.210, G:T.257
- pi-Stacking: I:Y.117
HSM.52: 8 residues within 4Å:- Chain A: D.98, Y.117
- Chain I: Y.152, E.210, S.211, Y.212, F.255, Y.260
7 PLIP interactions:4 interactions with chain A, 3 interactions with chain I- Hydrophobic interactions: A:Y.117
- Hydrogen bonds: A:D.98, A:D.98, I:Y.152, I:E.210, I:T.257
- pi-Stacking: A:Y.117
- 10 x CL: CHLORIDE ION(Non-functional Binders)
CL.9: 4 residues within 4Å:- Ligands: CL.20, CL.31, CL.42, CL.53
Ligand excluded by PLIPCL.10: 4 residues within 4Å:- Chain A: H.162, G.163
- Chain I: D.156, S.159
Ligand excluded by PLIPCL.20: 4 residues within 4Å:- Ligands: CL.9, CL.31, CL.42, CL.53
Ligand excluded by PLIPCL.21: 4 residues within 4Å:- Chain A: D.156, S.159
- Chain C: H.162, G.163
Ligand excluded by PLIPCL.31: 4 residues within 4Å:- Ligands: CL.9, CL.20, CL.42, CL.53
Ligand excluded by PLIPCL.32: 4 residues within 4Å:- Chain C: D.156, S.159
- Chain E: H.162, G.163
Ligand excluded by PLIPCL.42: 4 residues within 4Å:- Ligands: CL.9, CL.20, CL.31, CL.53
Ligand excluded by PLIPCL.43: 4 residues within 4Å:- Chain E: D.156, S.159
- Chain G: H.162, G.163
Ligand excluded by PLIPCL.53: 4 residues within 4Å:- Ligands: CL.9, CL.20, CL.31, CL.42
Ligand excluded by PLIPCL.54: 4 residues within 4Å:- Chain G: D.156, S.159
- Chain I: H.162, G.163
Ligand excluded by PLIP- 5 x V8D: Etomidate(Non-covalent)
V8D.11: 12 residues within 4Å:- Chain A: M.316, N.320, D.337, L.340, M.341, F.344, V.345
- Chain C: L.278, Q.279, M.282, P.283, L.286
6 PLIP interactions:4 interactions with chain A, 2 interactions with chain C- Hydrophobic interactions: A:L.340, A:F.344, A:V.345, C:L.278, C:L.286
- pi-Stacking: A:F.344
V8D.22: 12 residues within 4Å:- Chain C: M.316, N.320, D.337, L.340, M.341, F.344, V.345
- Chain E: L.278, Q.279, M.282, P.283, L.286
6 PLIP interactions:2 interactions with chain E, 4 interactions with chain C- Hydrophobic interactions: E:L.278, E:L.286, C:L.340, C:F.344, C:V.345
- pi-Stacking: C:F.344
V8D.33: 12 residues within 4Å:- Chain E: M.316, N.320, D.337, L.340, M.341, F.344, V.345
- Chain G: L.278, Q.279, M.282, P.283, L.286
6 PLIP interactions:2 interactions with chain G, 4 interactions with chain E- Hydrophobic interactions: G:L.278, G:L.286, E:L.340, E:F.344, E:V.345
- pi-Stacking: E:F.344
V8D.44: 12 residues within 4Å:- Chain G: M.316, N.320, D.337, L.340, M.341, F.344, V.345
- Chain I: L.278, Q.279, M.282, P.283, L.286
6 PLIP interactions:2 interactions with chain I, 4 interactions with chain G- Hydrophobic interactions: I:L.278, I:L.286, G:L.340, G:F.344, G:V.345
- pi-Stacking: G:F.344
V8D.55: 12 residues within 4Å:- Chain A: L.278, Q.279, M.282, P.283, L.286
- Chain I: M.316, N.320, D.337, L.340, M.341, F.344, V.345
6 PLIP interactions:2 interactions with chain A, 4 interactions with chain I- Hydrophobic interactions: A:L.278, A:L.286, I:L.340, I:F.344, I:V.345
- pi-Stacking: I:F.344
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- McMullan, G. et al., Structure determination by cryoEM at 100 keV. Proc.Natl.Acad.Sci.USA (2023)
- Release Date
- 2023-11-29
- Peptides
- Gamma-aminobutyric acid receptor subunit beta-3: ACEGI
Megabody Mb25: BDFHJ - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AG
AI
AB
OD
OF
OH
OJ
O - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-5-5-mer
- Ligands
- 5 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 5 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 5 x R16: HEXADECANE(Non-covalent)
- 20 x D10: DECANE(Non-covalent)
- 5 x HSM: HISTAMINE(Non-covalent)
- 10 x CL: CHLORIDE ION(Non-functional Binders)
- 5 x V8D: Etomidate(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- McMullan, G. et al., Structure determination by cryoEM at 100 keV. Proc.Natl.Acad.Sci.USA (2023)
- Release Date
- 2023-11-29
- Peptides
- Gamma-aminobutyric acid receptor subunit beta-3: ACEGI
Megabody Mb25: BDFHJ - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AG
AI
AB
OD
OF
OH
OJ
O - Membrane
-
We predict this structure to be a membrane protein.